Cargando…

Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease

INTRODUCTION: Graves’ disease is an autoimmune disorder caused by auto-antibodies against the thyroid stimulating hormone receptor (TSHR). Overstimulation of the TSHR induces hyperthyroidism and thyroid eye disease (TED) as the most common extra thyroidal manifestation of Graves’ disease. In TED, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gulbins, Anne, Horstmann, Mareike, Keitsch, Simone, Soddemann, Matthias, Wilker, Barbara, Wilson, Gregory C., Zeidan, Ryan, Hammer, Gary D., Daser, Anke, Bechrakis, Nikolaos E., Görtz, Gina-Eva, Eckstein, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558005/ https://www.ncbi.nlm.nih.gov/pubmed/37810891 http://dx.doi.org/10.3389/fendo.2023.1252727

Ejemplares similares

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023)

OR26-03 Treatment With Linsitinib, An IGF-1 Receptor Inhibitor, Prevents Disease Development And Progression In An Experimental Model Of Thyroid Eye Disease
por: Gulbins, Anne, et al.
Publicado: (2023)

Sphingolipids in thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023)

Influence of biological sex, age and smoking on Graves’ orbitopathy – a ten-year tertiary referral center analysis
por: Oeverhaus, Michael, et al.
Publicado: (2023)

Role of Tyrosine Nitrosylation in Stress-Induced Major Depressive Disorder: Mechanisms and Implications
por: Wilson, Gregory C., et al.
Publicado: (2023)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model
por: Schlüter, Anke, et al.
Publicado: (2018)

Proposing a surgical algorithm for graduated orbital decompression in patients with Graves’ orbitopathy
por: Stähr, Kerstin, et al.
Publicado: (2021)

Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease
por: Moshkelgosha, Sajad, et al.
Publicado: (2021)

Novel Insights into Pathophysiology of Orbital Inflammatory Diseases and Progression to Orbital Lymphoma by Pathway Enrichment Analysis
por: Al-Ghazzawi, Karim, et al.
Publicado: (2022)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
por: Wagner, Lilly H., et al.
Publicado: (2022)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

Preoperative preparation for Graves’ disease
por: Xu, Tianfeng, et al.
Publicado: (2023)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections
por: Becker, Katrin Anne, et al.
Publicado: (2021)

Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma
por: Schumacher, Fabian, et al.
Publicado: (2022)

Comprehensive Metabolomics Study in Children With Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
por: Villagelin, Danilo, et al.
Publicado: (2019)

Graves' Disease and the Post-partum Period: An Intriguing Relationship
por: Croce, Laura, et al.
Publicado: (2019)

Application of oral inorganic iodine in the treatment of Graves’ disease
por: Huang, Yixuan, et al.
Publicado: (2023)

Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis
por: Al-Ghazzawi, Karim, et al.
Publicado: (2022)

Inhaled sphingosine has no adverse side effects in isolated ventilated and perfused pig lungs
por: Carstens, Henning, et al.
Publicado: (2021)

Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis
por: Gardner, Aaron Ions, et al.
Publicado: (2021)

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease
por: Yao, Qiuming, et al.
Publicado: (2019)

Gut microbiota in experimental murine model of Graves’ orbitopathy established in different environments may modulate clinical presentation of disease
por: Masetti, Giulia, et al.
Publicado: (2018)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)

Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study
por: Struja, Tristan, et al.
Publicado: (2018)

Identification of Novel Environmental Substances Relevant to Pediatric Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Graves’ disease as a driver of depression: a mechanistic insight
por: Song, Yifei, et al.
Publicado: (2023)

Antimicrobial effects of inhaled sphingosine against Pseudomonas aeruginosa in isolated ventilated and perfused pig lungs
por: Carstens, Henning, et al.
Publicado: (2022)

Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020)

Intestinal microbiota changes in Graves’ disease: a prospective clinical study
por: Yan, Hui-xian, et al.
Publicado: (2020)

Graves’ Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study
por: Wu, Dide, et al.
Publicado: (2021)

Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review
por: Li, Jun, et al.
Publicado: (2021)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes
por: Wang, Lu-Ting, et al.
Publicado: (2023)

Dissecting the Genetic Susceptibility to Graves’ Disease in a Cohort of Patients of Italian Origin
por: Lombardi, Angela, et al.
Publicado: (2016)

Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease
por: Chen, Ziyi, et al.
Publicado: (2021)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections
por: Schnitker, Fabian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tb1sve7ed9nu68fk0jjhr1d1mc